36C10G22Q0004.docx

Combined Synopsis/Solicitation Notice

GENERAL INFORMATION

SET-ASIDE

OPAL | Strategic Acquisition Center

10300 Spotsylvania Ave | STE 400 Fredericksburg VA 22408-2697

POINT OF CONTACT*

Contract Specialist Ninatile Bacote Ninatile.Bacote@va.gov 202-957-2173

PLACE OF PERFORMANCE

ADDRESS

Nationwide

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

DESCRIPTION

Combined Synopsis/Solicitation Notice

Solicitation Number:

36C10G22Q0004

Notice Type:

Combined Synopsis/Solicitation

Synopsis:

COMBINED SYNOPSIS/SOLICITATION

This is a combined synopsis/solicitation for brand name or equal commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, “Streamlined Procedures for Evaluation and Solicitation for Commercial Items,” as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued.

Solicitation number 36C10G22Q0004 is issued for this combined synopsis/solicitation; this solicitation is being issued as a Request for Quote (RFQ). This combined synopsis/solicitation incorporates provisions and clauses in effect through Federal Acquisition Circular (FAC) 2021-07, dated 10 September 2021.

Requirement Description:

VA has a requirement to purchase Autotransfusion Units to deliver patient care at its VA Medical Centers around the country. Autotransfusion Units are designed to recover and deliver back a patient’s own blood during medium to high blood loss surgical procedures. This particular type of Autotransfusion Unit is a portable, lightweight electrical unit on wheels and is utilized in the operating room.

A single award Requirements contract will be awarded for the purchase of brand name or equal equipment in accordance with all terms, conditions, provisions, specifications, and schedule of this solicitation herein. Quotes shall contain the terms for cost/price and technical capabilities of the band name or equal equipment. The Government reserves the right to award without discussions.

The associated North American Industrial Classification System (NAICS) code for this procurement is 339112 – Surgical and Medical Instrument Manufacturing, Product Service Code: 6515 – Medical and Surgical Instruments, Equipment, and Supplies and the associated size standard is 1,000 employees. This procurement action is issued as full and open competition.

This acquisition is for a single award Requirements contract in accordance with FAR Part 16.5 for Haemonetics® brand name or equal Autotransfusion Units and related equipment and accessories as identified in ATTACHMENT A – NX EQ AUTOTRANSFUSION UNITS – PRICE COST SCHEDULE. All interested companies shall provide a quote for all Contract Line Item Numbers (CLINs) listed in ATTACHMENT A – NX EQ AUTOTRANSFUSION UNITS – PRICE COST SCHEDULE.

The ordering period is for one year with four 12-month option years. Delivery is FOB destination. Firm-Fixed Price Orders will be placed against this contract in writing and will provide the delivery locations, delivery dates and exact quantities.

The FAR provision at 52.212-1, Instructions to Offerors – Commercial, applies to this acquisition including attached addenda to the provision.

The FAR provision at 52.212-2, Evaluation -- Commercial Items, and the specific evaluation criteria as attached addenda also applies to this acquisition The Offeror is to include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications -- Commercial Items, with its offer.

Clause at 52.212-4, Contract Terms and Conditions -- Commercial Items, applies to this acquisition and a statement regarding any addenda to the clause. Addendum is attached.

Clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders -- Commercial Items, applies to this acquisition and a statement regarding which, if any, of the additional FAR clauses cited in the clause are applicable to the acquisition. Addendum is attached.

All interested quoters must be registered in the System for Award Management (SAM) prior to submitting a quote. You may access SAM at https://sam.gov/SAM/.

Questions regarding this combined synopsis/solicitation are due via email by 11:59PM EST on December 1, 2021 to Contract Specialist, Ninatile Bacote at Ninatile.Bacote@va.gov and Contracting Officer, David Barber at David.Barber@va.gov. No calls will be accepted.

Quotes are due via email by 11:59PM EST on December 17, 2021 to Contract Specialist, Ninatile Bacote at Ninatile.Bacote@va.gov and Contracting Officer, David Barber at David.Barber@va.gov.

Product Description Salient Characteristics Literature Review

1. SCOPE OF WORK:

The Veterans Health Administration (VHA) Non-Expendable Equipment National Program has identified the Autotransfusion Units product line as a candidate for a VA-wide (otherwise referred to as “national”) single Requirement contract award.

Autotransfusion Units are designed to recover and deliver back a patient’s own blood during medium to high blood loss surgical procedures. This particular type of Autotransfusion Unit is a portable, lightweight electrical unit on wheels and is utilized in the operating room.

The Contractor must demonstrate the ability to meet all requirements for the solicitation. The objective is to provide Autotransfusion Units to be used by clinicians throughout the VA medical centers and facilities. The period of performance is for one 12-month base period with four 12-month option periods.

2. REQUIREMENT

This requirement will be IAW FAR clause 52.211-6, “Brand Name or Equal” which requires the quoter to indicate that each product being offered as an “equal” product to the Haemonetics® brand name Autotransfusion Units. For each equal product, the quoter must include a description reflecting the salient characteristics (SC) and level of quality that will satisfy the salient physical, functional, or performance characteristics of the equal product(s) specified in the solicitation. The quoter must also clearly identify the item by brand name (if any) and make/model number. Finally, the quoter must include descriptive literature, such as illustrations, drawings, or a clear reference to previously furnished descriptive data or information available to the Contracting Officer, and clearly describe any modifications it plans to make to a product to make it conform to the solicitation requirements.

Any discontinued items will need to be clearly indicated and replacement/alternative model(s) will need to be provided as appropriate. Quoters are encouraged to include any commonly used accessory items and/or common available configurations.

The Department of Veterans Affairs (VA) is seeking vendors who can provide Haemonetics® brand name Autotransfusion Units as listed above or equal commodities which meet all of the following salient characteristics. Vendors may quote any product solution or configuration so long as they meet the salient characteristics. Vendors are asked to quote any additional product that may be beneficial. These items must be captured in the vendor’s pricing volume.

OF EVALUATION

PAGE # WHERE SC IS FOUND IN TECHNICAL LITERATURE

Hematocrit (Hct) Level ~ 60% RBC Recovery ~ 85% Washout Performance Albumin Removal ~ 98% Heparin Removal ~ 99% Potassium ~ 92% Literature Review

See attached document: ATTACHMENT A - PRICE COST SCHEDULE - NX EQ AUTOTRANSFUSION UNITS.

See attached document: ATTACHMENT B - CONTRACT ADMINISTRATION - NX EQ AUTOTRANSFUSION UNITS.

See attached document: ATTACHMENT C - CONTRACT CLAUSES - NX EQ AUTOTRANSFUSION UNITS.

See attached document: ATTACHMENT D - SOLICITATION PROVISIONS - NX EQ AUTOTRANSFUSION UNITS.

See attached document: ATTACHMENT E - REPORTING TOOL - NX EQ AUTOTRANSFUSION UNITS.

Page 1 of

Combined Synopsis/Solicitation Notice